{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Franklin",
      "state": "TN",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "72271",
      "recalling_firm": "Diabetes Corporation of America dba DCA Pharmacy",
      "address_1": "233 Bedford Way",
      "address_2": "N/A",
      "postal_code": "37064-5527",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Telephone",
      "distribution_pattern": "KY, OH, TN",
      "recall_number": "D-0006-2016",
      "product_description": "Sermorelin 6mg/6mL Lyophilized Powder, Sterile Compound for Subcutaneous Injection, Diabetes Corporation of America dba DCA Pharmacy, Franklin, TN 37064-5527",
      "product_quantity": "129 vials",
      "reason_for_recall": "Lack of Assurance of Sterility: A recent FDA inspection found that this product was not being compounded in an area appropriate for lyophilization which may lead to a lack of sterility assurance.",
      "recall_initiation_date": "20150923",
      "center_classification_date": "20151005",
      "termination_date": "20160112",
      "report_date": "20151014",
      "code_info": "Lot #: 101614, Exp 4/30/2015"
    }
  ]
}